ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Atebimetinib is on this study

  • The record lists it as a treatment, written “IMM-1-104 Monotherapy (Treatment Group A)”.
  • A model not recorded judged it tested: part of what the study tests. Nov 1, 2026, 6:35 AM UTC
  • The role rule says the same.
  • So Atebimetinib's page lists this study under “Testing it”.
8 links0 made here, not in the record12 judgments2 judges (the rules as one: Rule based)1 record change seen
Model not recordedRule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT05585320A Phase 1/2a Study ofIMM-1-104 in ParticipantsWith Advanced or MetastaticSolid TumorsImmuneering CorporationPhase 1/Phase 2 · active not rRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 20 · ClinicalTrials.gov record · Version of 2026-10-20Version of 2026-10-20CONDITIONSMelanoma, Cutaneous Maligna…The registry's MeSH filing›Nov 19 · Rule based · Finest filed termFinest filed termCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termNeoplasm MetastasisThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseAdenocarcinomaThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSAtebimetinibEntry “IMM-1-104 Monotherapy (Treatme…›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedINT010129Entry “IMM-1-104 + modified FOLFIRINO…›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedDabrafenibEntry “IMM-1-104 + dabrafenib (Treatm…›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedPembrolizumabEntry “IMM-1-104 + pembrolizumab (Tre…›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Oct 20 · changes seen, not judgments
Nov 1AtebimetinibA model not recordedTestedCurrent
Nov 1INT010129A model not recordedTestedCurrent
Nov 1DabrafenibA model not recordedTestedCurrent
Nov 1PembrolizumabA model not recordedTestedCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14Neoplasm MetastasisRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14AdenocarcinomaRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18AtebimetinibRule based · role ruleTestedAgrees
Nov 18INT010129Rule based · role ruleTestedAgrees
Nov 18DabrafenibRule based · role ruleTestedAgrees
Nov 18PembrolizumabRule based · role ruleTestedAgrees
Nov 19Melanoma, Cutaneous MalignantRule based · condition-kind ruleFinest filed termCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.